KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-Current Debt (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Non-Current Debt readings, the most recent being $14.0 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 13.65% to $14.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $14.0 billion, a 13.65% decrease, with the full-year FY2025 number at $15.0 billion, down 6.35% from a year prior.
  • Non-Current Debt hit $14.0 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $15.0 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $20.8 billion in Q1 2022 to a low of $14.0 billion in Q1 2026.
  • Median Non-Current Debt over the past 5 years was $16.8 billion (2025), compared with a mean of $17.5 billion.
  • Biggest five-year swings in Non-Current Debt: fell 15.68% in 2024 and later grew 2.23% in 2025.
  • Teva Pharmaceutical Industries' Non-Current Debt stood at $19.1 billion in 2022, then decreased by 4.93% to $18.2 billion in 2023, then dropped by 11.89% to $16.0 billion in 2024, then dropped by 6.35% to $15.0 billion in 2025, then decreased by 6.48% to $14.0 billion in 2026.
  • The last three reported values for Non-Current Debt were $14.0 billion (Q1 2026), $15.0 billion (Q4 2025), and $16.8 billion (Q3 2025) per Business Quant data.